Biosimilar drug development is unique and complex. At PRA, our cross-functional team of experts guide you through the many nuances of the biosimilar landscape and empower you with effective and efficient strategies to bring biosimilars to market. We built a global ecosystem of capabilities and relationships to successfully navigate this landscape. This includes understanding of the quality, analytical, nonclinical and clinical requirements of biosimilars while balancing the need to execute against competitive timelines.

Explore related content and topics